Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00032136
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research Campaign Clinical Trials Centre 4,400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499999
What this trial is testing

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaEstrogen-receptor-positive Breast Cancer+4 more
Dana-Farber Cancer Institute 140
Not applicableNot Yet RecruitingNCT07735897
What this trial is testing

Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women

Who this might be right for
Breast Cancer
MedicalExcellence 1,483
Large-scale testing (Phase 3)UnknownNCT00003418
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

Who this might be right for
Breast Cancer
International Collaborative Cancer Group 4,400
Early research (Phase 1)UnknownNCT00411840
What this trial is testing

Novel Therapy of PAD by Combined Transplantation of BMCs

Who this might be right for
Peripheral Arterial Disease
Heinrich-Heine University, Duesseldorf 100
Not applicableStudy completedNCT06855082
What this trial is testing

Using the Stoma Self-care Apps by Patients With Enterostomy

Who this might be right for
Enterostomy
HSIN LING CHEN 50
Not applicableStudy completedNCT00569543
What this trial is testing

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Nebraska 27
Not applicableStudy completedNCT07145827
What this trial is testing

Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen

Who this might be right for
Breast CancerEndometrial Hyperplasia and Endometrial Cancers
Uruk University 60
Testing effectiveness (Phase 2)Study completedNCT00365599
What this trial is testing

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 43
Large-scale testing (Phase 3)Active Not RecruitingNCT05952557
What this trial is testing

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Who this might be right for
Breast Cancer, Early Breast Cancer
AstraZeneca 5,511
Testing effectiveness (Phase 2)Study completedNCT00637871
What this trial is testing

Casodex - Nolvadex Combination

Who this might be right for
GynaecomastiaProstate Cancer
AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT02166944
What this trial is testing

Tamoxifen Treatment in Patients With Motor Neuron Disease

Who this might be right for
Amyotrophic Lateral SclerosisALS Functional Ration ScaleTAR-DNA-binding Protein-43+2 more
Taipei Medical University Shuang Ho Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT07616973
What this trial is testing

Letrozole vs. Clomiphene Citrate Plus Tamoxifen for Ovulation Induction and Pregnancy Outcomes.

Who this might be right for
Infertility DrugsInfertility Involuntary
Sana'a University 240
Testing effectiveness (Phase 2)Study completedNCT00632723
What this trial is testing

IRESSA™ (Gefitinib) in Breast Cancer Patients

Who this might be right for
Breast Cancer
AstraZeneca 54
Large-scale testing (Phase 3)Study completedNCT00784940
What this trial is testing

ATAC - Bone Density Sub-Protocol

Who this might be right for
Bone Density
AstraZeneca 308
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Study completedNCT03844685
What this trial is testing

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT07806630
What this trial is testing

SHORTened Duration of TAMoxifen

Who this might be right for
High Risk for Invasive Breast Cancer
Rutgers, The State University of New Jersey 250
Large-scale testing (Phase 3)Study completedNCT00038467
What this trial is testing

Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 4,740
Not applicableEnded earlyNCT01121549
What this trial is testing

A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

Who this might be right for
Invasive Early Breast Cancer
Pfizer 378
Next Page